[1] Fukui H , Saito H , Ueno Y , et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol, 2016, 51:629-650. [2] Bunchorntavakul C . Bacterial infections in cirrhosis: a critical review and practical guidance. World J Hepatol, 2016, 8:307. [3] Piotrowski D , Anna Boroń-Kaczmarska. Bacterial infections and hepatic encephalopathy in liver cirrhosis-prophylaxis and treatment. Adv Med Sci, 2017, 62:345. [4] Gravito-Soares M , Gravito-Soares E , Lopes S , et al. Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis. Eur J Gastroenterol Hepatol, 2017, 29:1010-1016. [5] 邵晶, 张磊, 韩国宏, 等. 肝硬化顽固性腹水的治疗现状. 中华肝脏病杂志, 2016, 24:721-723. [6] 中国侵袭性真菌感染工作组. 血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第五次修订版). 中华内科杂志, 2017, 56:453-459. [7] 许淑君,马雪娇,李家斌. 肝硬化失代偿期患者并发真菌感染危险因素分析. 安徽医学,2018,39:643-646. [8] Flemming, Alexandra. Fungal infection: JNK inhibitors boost antifungal immunity. Nat Rev Immunol, 2017, 17:148-149. [9] 曹凯淇. 肝硬化合并自发性细菌性腹膜炎与自发性真菌性腹膜炎的研究. 中国疗养医学, 2018, 27:29-31. [10] 郭栗良子,王立生. 肝硬化患者肠道菌群失衡的研究现状. 中国微生态学杂志,2018,30:104-108,113. [11] 黄耀强. 肝硬化患者口服益生菌后肠道菌群变化分析. 现代诊断与治疗,2017,28:1297-1299. [12] 王华富,桂志红,商振球,等.乙型肝炎肝硬化并发肺部感染79例病原菌分布及危险因素分析.中国乡村医药,2017,24:59-60. |